Browse Arkansas Code titles and sections
21 U.S.C. § 376 — Examination of sea food on request of
Federal law — U.S. Code and appendices · legal_authorities
Page 505
TITLE 21—FOOD AND DRUGS
§ 376
‘‘(B) provides for standardized methods for commu-
nications described in such paragraphs;
‘‘(C) establishes, with respect to inspections of both
domestic and foreign device establishments (as re-
ferred to in section 510(h)(2) of the Federal Food,
Drug, and Cosmetic Act [21 U.S.C. 360(h)(2)], as
amended by subsection (a) [of section 701 of Pub. L.
115–52]), a standard timeframe for such inspections—
‘‘(i) that occurs over consecutive days; and
‘‘(ii) to which each investigator conducting such
an inspection shall adhere unless the investigator
identifies to the establishment involved a reason
that more time is needed to conduct such investiga-
tion; and
‘‘(D) identifies practices for investigators and de-
vice establishments to facilitate the continuity of in-
spections of such establishments.
‘‘(2) FINAL GUIDANCE.—Not later than 1 year after pro-
viding notice and opportunity for public comment on
the draft guidance issued under paragraph (1), the Sec-
retary of Health and Human Services shall issue final
guidance to implement subsection (h) of section 704 of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
374), as added by subsection (a).’’
INSPECTIONS
Pub. L. 115–52, title VIII, § 806, Aug. 18, 2017, 131 Stat.
1073, provided that:
‘‘Within 6 months of the date of enactment of this
Act [Aug. 18, 2017], the Secretary of Health and Human
Services shall develop and implement a protocol for ex-
pediting review of timely responses to reports of obser-
vations from an inspection under section 704 of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 374). Such
protocol shall—
‘‘(1) apply to responses to such reports pertaining
to applications submitted under section 505 of the
Federal Food, Drug, and Cosme
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 376
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 7f6d2de3279e7cf8fbe061fbd8047933269787c8f26ea21d9fb8d7ee2a96cf25. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-8f64b8d61ffb660f0e101b23
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-376-examination-of-sea-food-on-request-of--56d2ed91ed.md
Pages: Not recorded – Not recorded
Passage SHA-256: 5142a93ac1f45dae0680c0b98fb1d5c0431b7ee1be63250a4fcdcbb7d3187671
Source location: USCODE-2024-title21-chap9-subchapVII-partA-sec376.pdf
Stored source content
Page 505
TITLE 21—FOOD AND DRUGS
§ 376
‘‘(B) provides for standardized methods for commu-
nications described in such paragraphs;
‘‘(C) establishes, with respect to inspections of both
domestic and foreign device establishments (as re-
ferred to in section 510(h)(2) of the Federal Food,
Drug, and Cosmetic Act [21 U.S.C. 360(h)(2)], as
amended by subsection (a) [of section 701 of Pub. L.
115–52]), a standard timeframe for such inspections—
‘‘(i) that occurs over consecutive days; and
‘‘(ii) to which each investigator conducting such
an inspection shall adhere unless the investigator
identifies to the establishment involved a reason
that more time is needed to conduct such investiga-
tion; and
‘‘(D) identifies practices for investigators and de-
vice establishments to facilitate the continuity of in-
spections of such establishments.
‘‘(2) FINAL GUIDANCE.—Not later than 1 year after pro-
viding notice and opportunity for public comment on
the draft guidance issued under paragraph (1), the Sec-
retary of Health and Human Services shall issue final
guidance to implement subsection (h) of section 704 of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
374), as added by subsection (a).’’
INSPECTIONS
Pub. L. 115–52, title VIII, § 806, Aug. 18, 2017, 131 Stat.
1073, provided that:
‘‘Within 6 months of the date of enactment of this
Act [Aug. 18, 2017], the Secretary of Health and Human
Services shall develop and implement a protocol for ex-
pediting review of timely responses to reports of obser-
vations from an inspection under section 704 of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 374). Such
protocol shall—
‘‘(1) apply to responses to such reports pertaining
to applications submitted under section 505 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C.
355)—
‘‘(A) for which the approval is dependent upon re-
mediation of conditions identified in the report;
‘‘(B) for which concerns related to observations
from an inspection under such section 704 are the
only barrier to approval; and
‘‘(C) where the drug that is the subject of the ap-
plication is a drug—
‘‘(i) for which there are not more than 3 other
approved applications under section 505(j) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C.
355(j)) that reference the same listed drug and for
which there are less than 6 abbreviated new drug
applications tentatively approved; or
‘‘(ii) that is included on the list under section
506E of such Act (21 U.S.C. 356e);
‘‘(2) address expedited re-inspection of facilities, as
appropriate; and
‘‘(3) establish a 6-month timeline for completion of
review of such responses to such reports.’’
AUTHORITY OF SECRETARY PRIOR TO OCTOBER 10, 1962
Pub. L. 87–781, title II, § 201(d), Oct. 10, 1962, 76 Stat.
793, provided that: ‘‘Nothing in the amendments made
by subsections (a) and (b) of this section [amending this
section] shall be construed to negate or derogate from
any authority of the Secretary existing prior to the en-
actment of this Act [Oct. 10, 1962].’’
Executive Documents
TRANSFER OF FUNCTIONS
For transfer of functions of Federal Security Admin-
istrator to Secretary of Health, Education, and Welfare
[now Health and Human Services], and of Food and
Drug Administration in the Department of Agriculture
to Federal Security Agency, see notes set out under
section 321 of this title.
§ 374a. Inspections relating to food allergens
The Secretary of Health and Human Services
shall conduct inspections consistent with the
authority under section 374 of this title of facili-
ties in which foods are manufactured, processed,
packed, or held—
(1) to ensure that the entities operating the
facilities comply with practices to reduce or
eliminate cross-contact of a food with residues
of major food allergens that are not inten-
tional ingredients of the food; and
(2) to ensure that major food allergens are
properly labeled on foods.
(Pub. L. 108–282, title II, § 205, Aug. 2, 2004, 118
Stat. 909.)
Editorial Notes
CODIFICATION
Section was enacted as a part of the Food Allergen
Labeling and Consumer Protection Act of 2004, and not
as part of the Federal Food, Drug, and Cosmetic Act
which comprises this chapter.
§ 375. Publicity
(a) Reports
The Secretary shall cause to be published from
time to time reports summarizing all judg-
ments, decrees, and court orders which have
been rendered under this chapter, including the
nature of the charge and the disposition thereof.
(b) Information regarding certain goods
The Secretary may also cause to be dissemi-
nated information regarding food, drugs, de-
vices, tobacco products, or cosmetics in situa-
tions involving, in the opinion of the Secretary,
imminent danger to health or gross deception of
the consumer. Nothing in this section shall be
construed to prohibit the Secretary from col-
lecting, reporting, and illustrating the results of
the investigations of the Department.
(June 25, 1938, ch. 675, § 705, 52 Stat. 1057; Pub. L.
111–31, div. A, title I, § 103(j), June 22, 2009, 123
Stat. 1837.)
Editorial Notes
AMENDMENTS
2009—Subsec. (b). Pub. L. 111–31 inserted ‘‘tobacco
products,’’ after ‘‘devices,’’.
Executive Documents
TRANSFER OF FUNCTIONS
For transfer of functions of Federal Security Admin-
istrator to Secretary of Health, Education, and Welfare
[now Health and Human Services], and of Food and
Drug Administration in the Department of Agriculture
to Federal Security Agency, see notes set out under
section 321 of this title.
§ 376. Examination of sea food on request of
packer; marking food with results; fees; pen-
alties
The Secretary, upon application of any packer
of any sea food for shipment or sale within the
jurisdiction of this chapter, may, at his discre-
tion, designate inspectors to examine and in-
spect such food and the production, packing, and
labeling thereof. If on such examination and in-
spection compliance is found with the provisions
of this chapter and regulations promulgated
thereunder, the applicant shall be authorized or
Page 506
TITLE 21—FOOD AND DRUGS
§ 377
required to mark the food as provided by regula-
tion to show such compliance. Services under
this section shall be rendered only upon pay-
ment by the applicant of fees fixed by regulation
in such amounts as may be necessary to provide,
equip, and maintain an adequate and efficient
inspection service. Receipts from such fees shall
be covered into the Treasury and shall be avail-
able to the Secretary for expenditures incurred
in carrying out the purposes of this section, in-
cluding expenditures for salaries of additional
inspectors when necessary to supplement the
number of inspectors for whose salaries Con-
gress has appropriated. The Secretary is author-
ized to promulgate regulations governing the
sanitary and other conditions under which the
service herein provided shall be granted and
maintained, and for otherwise carrying out the
purposes of this section. Any person who forges,
counterfeits, simulates, or falsely represents, or
without proper authority uses any mark, stamp,
tag, label, or other identification devices au-
thorized or required by the provisions of this
section or regulations thereunder, shall be
guilty of a misdemeanor, and shall on convic-
tion thereof be subject to imprisonment for not
more than one year or a fine of not less than
$1,000 nor more than $5,000, or both such impris-
onment and fine.
(June 25, 1938, ch. 675, § 706, formerly § 702A, for-
merly June 30, 1906, ch. 3915, § 10A, as added June
22, 1934, ch. 712, 48 Stat. 1204; amended Aug. 27,
1935, ch. 739, 49 Stat. 871; June 25, 1938, ch. 675,
§ 1002(a), formerly § 902(a), 52 Stat. 1059, renum-
bered § 1002(a), Pub. L. 111–31, div. A, title I,
§ 101(b)(2), June 22, 2009, 123 Stat. 1784; renum-
bered § 702A of act June 25, 1938, July 12, 1943, ch.
221, title II, 57 Stat. 500; Pub. L. 102–300, § 6(b)(2),
June 16, 1992, 106 Stat. 240; renumbered § 706,
Pub. L. 102–571, title I, § 106(3), Oct. 29, 1992, 106
Stat. 4498; Pub. L. 103–80, § 3(dd)(2), Aug. 13, 1993,
107 Stat. 779.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 372a of this
title prior to renumbering by Pub. L. 102–571.
Section, which formerly was not a part of the Federal
Food, Drug, and Cosmetic Act, originally was classified
to section 14a of this title. Section 1002(a) of act June
25, 1938, set out as an Effective Date note under section
301 of this title, provided that the section should re-
main in force and effect and be applicable to the provi-
sions of this chapter. Act July 12, 1943, renumbered this
section as 702A of the Federal Food, Drug, and Cos-
metic Act.
PRIOR PROVISIONS
A prior section 376, act June 25, 1938, ch. 675, § 706, 52
Stat. 1058, as amended, which related to listing and cer-
tification of color additives for foods, drugs, devices,
and cosmetics, was renumbered section 721 of act June
25, 1938, by Pub. L. 102–571, title I, § 106(4), Oct. 29, 1992,
106 Stat. 4498, and transferred to section 379e of this
title.
AMENDMENTS
1993—Pub. L. 103–80 struck out ‘‘of Agriculture’’ after
‘‘Secretary’’ in two places.
1992—Pub. L. 102–300, which directed the amendment
of the section by striking out ‘‘of Health, Education,
and Welfare’’ wherever appearing, could not be exe-
cuted because such words did not appear in the original
statutory text. See 1993 Amendment note above and
Transfer of Functions note below.
Statutory Notes and Related Subsidiaries
TRANSFER OF FUNCTIONS
Secretary and Department of Health, Education, and
Welfare redesignated Secretary and Department of
Health and Human Services by Pub. L. 96–88, title V,
§ 509(b), Oct. 17, 1979, 93 Stat. 695, which is classified to
section 3508(b) of Title 20, Education.
Executive Documents
TRANSFER OF FUNCTIONS
For transfer of functions of Federal Security Admin-
istrator to Secretary of Health, Education, and Welfare
[now Health and Human Services], and of Food and
Drug Administration in the Department of Agriculture
to Federal Security Agency, see notes set out under
section 321 of this title.
§ 377. Revision of United States Pharmacopoeia;
development of analysis and mechanical and
physical tests
The Secretary, in carrying into effect the pro-
visions of the Federal Food, Drug, and Cosmetic
Act [21 U.S.C. 301 et seq.], is authorized on and
after July 12, 1943, to cooperate with associa-
tions and scientific societies in the revision of
the United States Pharmacopoeia and in the de-
velopment of methods of analysis and mechan-
ical and physical tests necessary to carry out
the work of the Food and Drug Administration.
(July 12, 1943, ch. 221, title II, 57 Stat. 500; 1953
Reorg. Plan No. 1, § 5, eff. Apr. 11, 1953, 18 F.R.
2053, 67 Stat. 631.)
Editorial Notes
REFERENCES IN TEXT
The Federal Food, Drug, and Cosmetic Act, referred
to in text, is act June 25, 1938, ch. 675, 52 Stat. 1040,
which is classified generally to this chapter. For com-
plete classification of this Act to the Code, see section
301 of this title and Tables.
CODIFICATION
Section was enacted as part of the Labor-Federal Se-
curity Appropriation Act, 1944, and not as part of the
Federal Food, Drug, and Cosmetic Act which comprises
this chapter.
Executive Documents
TRANSFER OF FUNCTIONS
For transfer of functions of Federal Security Admin-
istrator to Secretary of Health, Education, and Welfare
[now Health and Human Services], and of Food and
Drug Administration in the Department of Agriculture
to Federal Security Agency, see notes set out under
section 321 of this title.
§ 378. Advertising of foods
(a) Determination of misbranding; notification of
Federal Trade Commission by Secretary;
contents
(1) Except as provided in subsection (c), before
the Secretary may initiate any action under
subchapter III—
(A) with respect to any food which the Sec-
retary determines is misbranded under section
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
This chapter may be cited as the Federal Food, Drug, and Cosmetic Act.
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 301
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 30
TITLE 21—FOOD AND DRUGS
§ 301
Sec.
398.
Notices to States regarding imported food.
399.
Grants to enhance food safety.
399a.
Office of the Chief Scientist.
399b.
Office of Women’s Health.
399c.
Improving the training of State, local, terri-
torial, and tribal food safety officials.
399d.
Employee protections.
399e.
Nanotechnology.
399f.
Ensuring
adequate
information
regarding
pharmaceuticals for all populations, par-
ticularly underrepresented subpopulations,
including racial subgroups.
399g.
Food and Drug Administration Intercenter
Institutes.
399h.
National Centers of Excellence in Advanced
and Continuous Pharmaceutical Manufac-
turing.
399i.
Food and Drug Administration Working Cap-
ital Fund.
SUBCHAPTER I—SHORT TITLE
§ 301. Short title
This chapter may be cited as the Federal
Food, Drug, and Cosmetic Act.
(June 25, 1938, ch. 675, § 1, 52 Stat. 1040.)
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE; POSTPONEMENT IN CERTAIN CASES
Act June 23, 1939, ch. 242, §§ 1, 2, 53 Stat. 853, 854, pro-
vided that:
‘‘[SEC. 1] (a) The effective date of the following provi-
sions of the Federal Food, Drug, and Cosmetic Act is
hereby postponed until January 1, 1940: Sections 402(c)
[342(c) of this title]; 403(e)(1) [343(e)(1) of this title];
403(g), (h), (i), (j), and (k) [343(g) to (k) of this title];
501(a), (4) [351(a)(4) of this title]; 502(b), (d), (e), (f), (g),
and (h) [352(b), (d) to (h) of this title]; 601(e) [361(e) of
this title]; and 602(b) [362(b) of this title].
‘‘(b) The Secretary of Agriculture shall promulgate
regulations further postponing to July 1, 1940[,] the ef-
fective date of the provisions of sections 403(e)(1)
[343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g)
to (k)]; 502(b), (d), (
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 301
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Necessity of effective approval of application** No person shall introduce or deliver for introduction into interstate commerce any new drug, unless an approval of an application filed pursuant to subsection (b) or (j) is effective with respect to such drug.
**(b) Filing application; contents**
(1)
(A) Any person may file with the Secretary an application with respect to any drug subject to the provisions of subsection (a). Such persons shall submit to the Secretary as part of the application—
(i) full reports of investigations which have been made to show whether such drug is safe for use and whether such drug is effective in use;
(ii) a full list of the articles used as components of such drug;
(iii) a full statement of the composition of such drug;
(iv) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug;
(v) such samples of such drug and of the articles used as components thereof as the Secretary may require;
(vi) specimens of the labeling proposed to be used for such drug;
(vii) any assessments required under [section 355c of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section355c&num=0&edition=prelim); and
(viii) the patent number and expiration date of each patent for which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner of the patent engaged in the manufacture, use, or sale of the drug, and that—
(I) claims the drug for which the applicant submitted the application and is a drug substance (active ingredient) patent or a drug product (formulation or composition) patent; or
(II) claims a method of using such drug for which approv
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 355
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 355. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 186
TITLE 21—FOOD AND DRUGS
§ 355
§ 355. New drugs
(a) Necessity of effective approval of application
No person shall introduce or deliver for intro-
duction into interstate commerce any new drug,
unless an approval of an application filed pursu-
ant to subsection (b) or (j) is effective with re-
spect to such drug.
(b) Filing application; contents
(1)(A) Any person may file with the Secretary
an application with respect to any drug subject
to the provisions of subsection (a). Such persons
shall submit to the Secretary as part of the ap-
plication—
(i) full reports of investigations which have
been made to show whether such drug is safe
for use and whether such drug is effective in
use;
(ii) a full list of the articles used as compo-
nents of such drug;
(iii) a full statement of the composition of
such drug;
(iv) a full description of the methods used in,
and the facilities and controls used for, the
manufacture, processing, and packing of such
drug;
(v) such samples of such drug and of the arti-
cles used as components thereof as the Sec-
retary may require;
(vi) specimens of the labeling proposed to be
used for such drug;
(vii) any assessments required under section
355c of this title; and
(viii) the patent number and expiration date
of each patent for which a claim of patent in-
fringement could reasonably be asserted if a
person not licensed by the owner of the patent
engaged in the manufacture, use, or sale of the
drug, and that—
(I) claims the drug for which the applicant
submitted the application and is a drug sub-
stance (active ingredient) patent or a drug
product (formulation or composition) pat-
ent; or
(II) claims a method of using such drug for
which approval is sought or has been granted
in the application.
(B) If an a
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 355
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 355. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment** The Secretary shall maintain an up-to-date list of drugs that are determined by the Secretary to be in shortage in the United States.
**(b) Contents** For each drug on such list, the Secretary shall include the following information:
(1) The name of the drug in shortage, including the National Drug Code number for such drug.
(2) The name of each manufacturer of such drug.
(3) The reason for the shortage, as determined by the Secretary, selecting from the following categories:
(A) Requirements related to complying with good manufacturing practices.
(B) Regulatory delay.
(C) Shortage of an active ingredient.
(D) Shortage of an inactive ingredient component.
(E) Discontinuance of the manufacture of the drug.
(F) Delay in shipping of the drug.
(G) Demand increase for the drug.
(4) The estimated duration of the shortage as determined by the Secretary.
**(c) Public availability**
(1) **In general** — Subject to paragraphs (2) and (3), the Secretary shall make the information in such list publicly available.
(2) **Trade secrets and confidential information** — Nothing in this section alters or amends [section 1905 of title 18](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title18-section1905&num=0&edition=prelim) or [section 552(b)(4) of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section552/b/4&num=0&edition=prelim).
(3) **Public health exception** — The Secretary may choose not to make information collected under this section publicly available under paragraph (1) or [section 356c(c) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section356c/c&num=0&edition=prelim) if the Secretary determines that disclosure of such information would advers
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 356e
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 356e. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 288
TITLE 21—FOOD AND DRUGS
§ 356e
(1) be subject to judicial review; or
(2) be construed to establish a defense to an
enforcement action by the Secretary.
(f) Temporary sunset
Subsection (a) shall cease to be effective on
the date that is 5 years after July 9, 2012. Sub-
sections (b), (c), and (e) shall not be in effect
during the period beginning 5 years after July 9,
2012, and ending on December 29, 2022. Sub-
sections (b), (c), and (e) shall be in effect begin-
ning on December 29, 2022.
(g) Coordination
The Secretary shall ensure timely and effec-
tive internal coordination and alignment among
the field investigators of the Food and Drug Ad-
ministration and the staff of the Center for Drug
Evaluation and Research’s Office of Compliance
and Drug Shortage Program regarding—
(1) the reviews of reports shared pursuant to
section 374(b)(2) of this title; and
(2) any feedback or corrective or preventive
actions in response to such reports.
(June 25, 1938, ch. 675, § 506D, as added Pub. L.
112–144, title X, § 1003, July 9, 2012, 126 Stat. 1103;
amended Pub. L. 117–328, div. FF, title III,
§ 3616(a), Dec. 29, 2022, 136 Stat. 5874.)
Editorial Notes
AMENDMENTS
2022—Subsec. (f). Pub. L. 117–328, § 3616(a)(2), amended
subsec. (f) generally. Prior to amendment, text read as
follows: ‘‘Subsections (a), (b), (c), and (e) shall cease to
be effective on the date that is 5 years after July 9,
2012.’’
Subsec. (g). Pub. L. 117–328, § 3616(a)(1), added subsec.
(g).
§ 356e. Drug shortage list
(a) Establishment
The Secretary shall maintain an up-to-date
list of drugs that are determined by the Sec-
retary to be in shortage in the United States.
(b) Contents
For each drug on such list, the Secretary shall
include the following information:
(1) The
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 356e
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 356e. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Definitions** As used in this section—
(1) the term “manufacture, preparation, propagation, compounding, or processing” shall include repackaging or otherwise changing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user; and
(2) the term “name” shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation.
**(b) Annual registration**
(1) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or drugs shall register with the Secretary the name of such person, places of business of such person, all such establishments, the unique facility identifier of each such establishment, and a point of contact e-mail address.
(2) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a device or devices shall register with the Secretary his name, places of business, and all such establishments.
(3) The Secretary shall specify the unique facility identifier system that shall be used by registrants under paragraph (1). The requirement to include a unique facility identifier in a registration under paragraph (1) shall not apply until the date that the identifier system is specified by the Secretary under the pr
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 301
TITLE 21—FOOD AND DRUGS
§ 360
1 So in original.
sections 358 to 360 of this title, amended sections 351 to
353, 355, and 357 of this title, and enacted provisions set
out as notes under sections 352, 355, 358, and 360 of this
title.
The Drug Amendments of 1962, referred to in text, is
Pub. L. 87–781, Oct. 10, 1962, 76 Stat. 780, as amended.
For complete classification of this Act to the Code, see
Short Title of 1962 Amendment note set out under sec-
tion 301 of this title and Tables.
§ 360. Registration of producers of drugs or de-
vices
(a) Definitions
As used in this section—
(1) the term ‘‘manufacture, preparation,
propagation,
compounding,
or
processing’’
shall include repackaging or otherwise chang-
ing the container, wrapper, or labeling of any
drug package or device package in furtherance
of the distribution of the drug or device from
the original place of manufacture to the per-
son who makes final delivery or sale to the ul-
timate consumer or user; and
(2) the term ‘‘name’’ shall include in the
case of a partnership the name of each partner
and, in the case of a corporation, the name of
each corporate officer and director, and the
State of incorporation.
(b) Annual registration
(1) During the period beginning on October 1
and ending on December 31 of each year, every
person who owns or operates any establishment
in any State engaged in the manufacture, prepa-
ration, propagation, compounding, or processing
of a drug or drugs shall register with the Sec-
retary the name of such person, places of busi-
ness of such person, all such establishments, the
unique facility identifier of each such establish-
ment, and a point of contact e-mail address.
(2) During the period beginning on October 1
and ending on December 31 of ea
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 360
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Right of agents to enter; scope of inspection; notice; promptness; exclusions**
(1) For purposes of enforcement of this chapter, officers or employees duly designated by the Secretary, upon presenting appropriate credentials and a written notice to the owner, operator, or agent in charge, are authorized (A) to enter, at reasonable times, any factory, warehouse, or establishment in which food, drugs, devices, tobacco products, or cosmetics are manufactured, processed, packed, or held, for introduction into interstate commerce or after such introduction, or to enter any vehicle being used to transport or hold such food, drugs, devices, tobacco products, or cosmetics in interstate commerce; and (B) to inspect, at reasonable times and within reasonable limits and in a reasonable manner, such factory, warehouse, establishment, or vehicle and all pertinent equipment, finished and unfinished materials, containers, and labeling therein. In the case of any person (excluding farms and restaurants) who manufactures, processes, packs, transports, distributes, holds, or imports foods, the inspection shall extend to all records and other information described in [section 350c of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c&num=0&edition=prelim), when the standard for records inspection under paragraph (1) or (2) of [section 350c(a) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/a&num=0&edition=prelim) applies, subject to the limitations established in [section 350c(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/d&num=0&edition=prelim). In the case of a facility (as defined in [section 364 of this title](https://uscode.house.gov/vi
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 374
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 374. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 495
TITLE 21—FOOD AND DRUGS
§ 374
kind of food, drug, device, tobacco product, or
cosmetic to which such request relates, except
that evidence obtained under this section, or
any evidence which is directly or indirectly de-
rived from such evidence, shall not be used in a
criminal prosecution of the person from whom
obtained, and except that carriers shall not be
subject to the other provisions of this chapter
by reason of their receipt, carriage, holding, or
delivery of food, drugs, devices, tobacco prod-
ucts, or cosmetics in the usual course of busi-
ness as carriers, except as provided in subsection
(b).
(b) Food transportation records
A shipper, carrier by motor vehicle or rail ve-
hicle, receiver, or other person subject to sec-
tion 350e of this title shall, on request of an offi-
cer or employee designated by the Secretary,
permit the officer or employee, at reasonable
times, to have access to and to copy all records
that the Secretary requires to be kept under
section 350e(c)(1)(E) of this title.
(June 25, 1938, ch. 675, § 703, 52 Stat. 1057; Pub. L.
91–452, title II, § 230, Oct. 15, 1970, 84 Stat. 930;
Pub. L. 103–80, § 3(z), Aug. 13, 1993, 107 Stat. 778;
Pub. L. 109–59, title VII, § 7202(c), Aug. 10, 2005,
119 Stat. 1913; Pub. L. 111–31, div. A, title I,
§ 103(h), June 22, 2009, 123 Stat. 1837.)
Editorial Notes
AMENDMENTS
2009—Subsec. (a). Pub. L. 111–31 inserted ‘‘tobacco
product,’’ after ‘‘device,’’ in two places and ‘‘tobacco
products,’’ after ‘‘devices,’’ in two places.
2005—Pub. L. 109–59 struck out ‘‘of interstate ship-
ment’’ after ‘‘Records’’ in section catchline, designated
existing provisions as subsec. (a), inserted subsec. head-
ing, substituted ‘‘carriers, except as provided in sub-
section (b)’’ for ‘‘carriers’’ b
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 374
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 374. This identifies an authority to review, not proof of applicability.